• Corpus ID: 41423172

Enhancing effects of alpha-,beta-monoglycosylceramides on natural killer cell activity.

@article{Kobayashi1996EnhancingEO,
  title={Enhancing effects of alpha-,beta-monoglycosylceramides on natural killer cell activity.},
  author={Eiichi Kobayashi and Kazuhiro Motoki and Yasunori Yamaguchi and Takeshi Uchida and H. Fukushima and Y. Koezuka},
  journal={Bioorganic \& medicinal chemistry},
  year={1996},
  volume={4 4},
  pages={
          615-9
        }
}
We examined the in vitro and in vivo natural killer (NK) cell activity enhancing effects of alpha-, beta-galactosylceramide (GalCer) and alpha-, beta-glucosylceramide (GluCer) which have the same ceramide moiety, and of other alpha-, beta-GalCer having a different ceramide portion, and found that alpha-types show stronger enhancing effects than beta-types and the alpha-GalCer possesses the most potent activity among GalCers and GluCers having the same ceramide moiety. When the comparison of… 
Tumor specific cytotoxicity of β-glucosylceramide: structure–cytotoxicity relationship and anti-tumor activity in vivo
TLDR
The antitumor activity of β-GluCer in vivo is demonstrated, and the mechanisms responsible for the growth inhibition are discussed, pointing to the importance of the hydrophilicity of the ceramide molecule rather than the chemical structure for the cyto-selectivity.
Beta-Glucosylceramide Administration (i.p.) Activates Natural Killer T cells In Vivo and Prevents Tumor Metastasis in Mice
TLDR
It is demonstrated that β-GlcCer treatment activates invariant NKT cells, thus resulting in the inhibition of tumor metastasis, as well as increasing the cytotoxicity of hepatic lymphocytes against tumor cells.
Stimulation of Natural Killer T Cells by Glycolipids
TLDR
Control over NKT cell responses by designed glycolipids has not been optimized, and further research will be required to fully reveal the therapeutic potential of this cell type.
Interleukin-2 gene transfer potentiates the α-galactosylceramide-stimulated antitumor effect by the induction of TRAIL in NKT and NK cells in mouse models of subcutaneous and metastatic carcinoma
TLDR
This study shows the efficacy of α-GalCer/AdmIL-2 immunomodulatory therapy, and provides a cellular mechanism on how it exerts the antitumor effects.
Regulation of antitumour immunity by CD1d‐restricted NKT cells
TLDR
CD1d‐restricted NKT cells are a highly specialized cell type that, in contrast to conventional T cells, recognize lipid/glycolipid antigens presented by the non‐classical MHC molecule CD1d.